We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
(-4.4%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$41.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.6M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$29.6M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.3M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$46M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$45.2M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$41.1M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$28.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.86% |
| 2 | Financials | 4.76% |
| 3 | Consumer Discretionary | 4.5% |
| 4 | Healthcare | 4.18% |
| 5 | Consumer Staples | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Lamb Weston
LW
$7.39B
| $932K | 0.01% |
12,043
+1,834
| +18% | +$143K |
|
1527
PENN Entertainment
PENN
$2.53B
| $932K | 0.01% |
33,886
-2,807
| -8% | -$90.6K |
|
1528
Qorvo
QRVO
$8.68B
| $932K | 0.01% |
11,740
-298
| -2% | -$28.8K |
|
1529
Las Vegas Sands
LVS
$29.6B
| $931K | 0.01% |
24,814
-1,814
| -7% | -$67.6K |
|
1530
Lumen
LUMN
$6.6B
| $929K | 0.01% |
127,642
+9,131
| +8% | +$92.9K |
|
1531
Magna International
MGA
$18.7B
| $924K | 0.01% |
19,476
+1,476
| +8% | +$85.9K |
|
|
IBML
1532
DELISTED
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
| $923K | 0.01% |
36,558
+10,815
| +42% | +$275K |
|
|
DFP
1533
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$428M
| $922K | 0.01% |
48,529
-7,214
| -13% | -$155K |
|
1534
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.13B
| $921K | 0.01% |
10,520
-546
| -5% | -$52.8K |
|
1535
AutoNation
AN
$6.89B
| $919K | 0.01% |
9,019
+803
| +10% | +$94.2K |
|
1536
Invesco Pharmaceuticals ETF
PJP
$497M
| $919K | 0.01% |
12,890
-2,116
| -14% | -$158K |
|
1537
CVR Partners
UAN
$1.26B
| $919K | 0.01% |
8,027
+633
| +9% | +$72.2K |
|
1538
State Street SPDR Russell 1000 Yield Focus ETF
ONEY
$681M
| $916K | 0.01% |
10,988
+954
| +10% | +$88.8K |
|
1539
Sturm, Ruger & Co
RGR
$601M
| $915K | 0.01% |
18,025
-3,442
| -16% | -$199K |
|
|
HTD
1540
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$904M
| $914K | 0.01% |
43,630
-93
| -0.2% | -$2.2K |
|
1541
Invesco Active US Real Estate Fund
PSR
$59.9M
| $913K | 0.01% |
10,754
+164
| +2% | +$16.1K |
|
1542
West Pharmaceutical
WST
$24.4B
| $913K | 0.01% |
3,712
-484
| -12% | -$147K |
|
|
HBI
1543
DELISTED
Hanesbrands
HBI
| $907K | 0.01% |
130,329
+30,395
| +30% | +$298K |
|
1544
Invesco MSCI Sustainable Future ETF
ERTH
$138M
| $906K | 0.01% |
18,583
+3,244
| +21% | +$181K |
|
1545
Howmet Aerospace
HWM
$113B
| $905K | 0.01% |
29,260
+802
| +3% | +$28.1K |
|
1546
PACCAR
PCAR
$68.8B
| $905K | 0.01% |
16,223
+1,830
| +13% | +$106K |
|
1547
Sea Limited
SE
$75.5B
| $905K | 0.01% |
16,141
+239
| +2% | +$16.6K |
|
1548
SentinelOne
S
$8.17B
| $904K | 0.01% |
35,371
+2,335
| +7% | +$61.3K |
|
1549
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$796M
| $902K | 0.01% |
35,900
-62,010
| -63% | -$1.7M |
|
1550
Adaptive Alpha Opportunities ETF
AGOX
$394M
| $901K | 0.01% |
46,967
+36,093
| +332% | +$760K |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
- Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
- Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
- Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
- Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
- Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.